Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates

Adv Pharmacol. 1998:42:211-4. doi: 10.1016/s1054-3589(08)60730-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • Brain / metabolism*
  • Carbon Radioisotopes
  • Carrier Proteins / analysis*
  • Carrier Proteins / metabolism
  • Cocaine / analogs & derivatives*
  • Cocaine / pharmacokinetics
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine Uptake Inhibitors / pharmacokinetics*
  • Humans
  • Membrane Glycoproteins*
  • Membrane Transport Proteins*
  • Methylphenidate / pharmacology
  • Nerve Tissue Proteins*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / metabolism
  • Primates
  • Radioligand Assay
  • Radiopharmaceuticals*
  • Reference Values
  • Substance-Related Disorders / diagnostic imaging
  • Substance-Related Disorders / metabolism
  • Tomography, Emission-Computed / methods

Substances

  • Carbon Radioisotopes
  • Carrier Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine Uptake Inhibitors
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Radiopharmaceuticals
  • Methylphenidate
  • (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester
  • Cocaine
  • Dopamine